MedTrace Logo

Education Program to Reduce Risky Behavior in Adolescents Ph I

NCT05607784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2023-09-15

No results posted yet for this study

Summary

This phase will complete the TRAC adaptation to a web app. The pilot study (R21 HD089979) effectively translated the ER content of TRAC and the same procedures will be used to translate the remaining content.

Conditions

  • Risky Sexual Behavior
  • Emotional Regulation
  • Adolescent Behavior

Interventions

BEHAVIORAL

Formative Research- Content Translation

This formative research includes brainstorming translation of content and reviewing wireframe prototypes generated from this process. It also includes attending to cultural, developmental, and gender considerations. The design development cycles will begin with advisory focus group feedback about how the existing activities convey the content (i.e., what and how they are learning). They will advise on activity design for the remaining content (sexual health and content connecting this with ER) to ensure these are engaging, appropriate, and informative. They will also provide perspectives about design, structure, navigability, and approach

BEHAVIORAL

Formative Research- Content Feedback and Acceptability

This formative research includes providing feedback on the proposed content and ensure contextual acceptability in schools. The design development cycles will begin with advisory focus group feedback about how the existing activities convey the content (i.e., what and how they are learning). They will advise on activity design for the remaining content (sexual health and content connecting this with ER) to ensure these are engaging, appropriate, and informative. They will also provide perspectives about design, structure, navigability, and approach

Sponsors & Collaborators

  • Rhode Island Hospital

    collaborator OTHER

  • University of Oregon

    collaborator OTHER

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • Christopher D Houck, PhD · Rhode Island Hospital

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2023-06-30
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05607784 on ClinicalTrials.gov